
ALLOGENE THERAPEUTICS INC
ALLONASDAQ๐ #2510 by market capEarnings Aug 12US Equity
$2.12โฒ $0.00 (+0.00%)
Live1hโฒ 1.2%
24hโฒ 0.0%
7dโฒ 8.7%
14dโฒ 16.8%
30dโฒ 9.6%
1yโฒ 106.8%
๐ฆMarket Cap
$732M
Small Cap
๐Revenue Growth (YoY)
-100.0%
Declining
๐Gross Margin
0.0%
Thin
๐ตFCF Margin
0.0%
Thin
โ๏ธP/S Ratio
0.0x
Cheap
Otter Score
57
Weak
Earnings
Q2 ยท 2026Reported 2026-05-13Earnings Per Share
Actual
-0.18
Expected
-0.19
beat
+5.30%
YoY +35.70%
Revenue
Actual
โ
Expected
$2.22K
โ
โ
Consensus estimates
Recent quarters
Q2 2026
-0.18
beat
Q1 2026
-0.17
beat
Q4 2025
-0.19
beat
Q3 2025
-0.23
beat